secwatch / observer
8-K filed January 9, 2024, 6:59 PM ET ticker CDNA CIK 0001217234
earnings confidence high sentiment positive materiality 0.70

CareDx prelim FY2023 revenue $279-280M, above high end of guidance; Q4 patient volumes up 4% QoQ

CareDx, Inc.

2023-FY EPS reported -$3.54 revenue$280,324,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CareDx, Inc. reported the fourth quarter ended December 31, 2023 results: revenue between $65 million and $66 million.

Period
the fourth quarter ended December 31, 2023
Revenue
between $65 million and $66 million
Result
preliminary results
Exact text from the filing
Preliminary revenue for the three months ended December 31, 2023, is expected to be between $65 million and $66 million
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CareDx, Inc. reported the full year ended December 31, 2023 results: revenue between $279 million and $280 million.

Period
the full year ended December 31, 2023
Revenue
between $279 million and $280 million
Result
preliminary results
Exact text from the filing
Preliminary revenue for the full year ended December 31, 2023, is expected to be between $279 million and $280 million
View on SEC.gov

Browse all earnings releases →

CareDx, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-24-004834
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.